Pharmaceutical distributors seek two-year delay in DSCSA tracking rules
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicySupply Chain Management